GEIST:UPC Searchengine

ORD_44709/2024

Amgen AB, Amgen s.r.l., Amgen GmbH, Amgen Technology (Ireland) Unlimited Company, Amgen Biofarmacêutica Lda., Amgen S.A.S., Amgen Zdravila D.O.O., Amgen N.V.

Date
2024-08-08
Division
Luxembourg (LU)
Type of action
Generic application
Language
EN

Metadata

Case IDORD_44709-2024-289ee0991426
Case number
Registry numberORD_44709/2024
Order referenceORD_44709/2024
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 3

1 ORDER of the Court of Appeal of the Unified Patent Court issued on 8 August 2024 HEADNOTES - It follows from Rule 278.1 and 2 RoP that written pleadings, like the Statement of grounds of appeal in the case-at-hand, are served by the Registry in the electronic CMS of the Court unless service cannot be effected by means of electronic communication. - Prior communication between the parties themselves of the written pleading via another electronic system like the German special electronic lawyer’s mailbox (besonderes elektronisches Anwaltspostfach, (beA)) cannot be considered as effective service under Rule 278.1 RoP. KEYWORD - Service APPELLANT (APPLICANT IN THE PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE) Alexion Pharmaceuticals, Inc. 121 Seaport Blvd, 02210 Boston (MA), United States  ...